Ignite Creation Date:
2025-12-24 @ 10:38 PM
Ignite Modification Date:
2025-12-28 @ 4:31 PM
Study NCT ID:
NCT01458535
Status:
COMPLETED
Last Update Posted:
2016-07-11
First Post:
2011-09-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2013-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-23
First Submit QC Date:
None
Study First Post Date:
2011-10-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-31
Results First Submit QC Date:
None
Results First Post Date:
2016-07-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-06-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-05-31
Last Update Post Date:
2016-07-11
Last Update Post Date Type:
ESTIMATED